StratDeckAMGN

Amgen Inc.

AMGN—
Share

Healthcare · Drug Manufacturers - General · United States

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Price381.50USD
1D+1.10%
Market cap206B
AnalystsHold29
Next earnings3 Nov
Loading chart…

Trade ideas

AMGN isn't in any strategy's Top Picks or Good Opportunities today.

Analysts

ConsensusHold29
Mean score2.59
Mean target388.03+1.71%
Target range225.00–457.00

Value vs sector peers

#14 of 26 in HealthcarePaying up for quality44
  • Fwd P/E15.652
  • P/B17.65
  • Yield2.7%52
  • P/E23.771
  • Rev growth+9.5%64

Nearest in Healthcare

  1. #12UNHUnitedHealth Group IncorporatedCheap for a reason49
  2. #13ABTAbbott LaboratoriesStronger than peers47
  3. #14AMGNAmgen Inc.Paying up for quality44
  4. #15RO.SWRoche Holding AGWeakest in sector42

Fundamentals

P/E23.7
Forward P/E15.6
Price / book17.65
Dividend yield2.67%
Beta0.43
52-week range269.77–447.0363/100
ADV (USD)1.09B
Relative volume1.2
10d avg volume2.86M
Revenue growth+9.50%
EPS growth+64.90%

Performance

1D+1.10%
7D-12.75%
1M-7.58%
3M+9.47%
6M+5.56%
YTD+18.94%

In the briefing and the feed

Briefing for 11 Sept

Neither the briefing nor the research feed has named AMGN.

Catalysts

Next earnings: 3 Nov

Trade idea history

No trade idea has fired on AMGN since the ledger opened.

Get it by email

The board AMGN sits on, in one five-minute email every weekday before the New York open and on Saturdays: market strength, the biggest movers, earnings coming up and the names sitting at their 200-day EMA.